Videos
COO Tom Mitro visits with OISTV to give an update on Aerie’s clinical trial progress. 00:25 – Update on Rhopressa. What’s the good news? 00:39…
Read More
By Michael Lachman The cataract surgery premium channel consists primarily of presbyopia-correcting intraocular lenses (PC-IOLs), toric IOLs that correct astigmatism, and femtosecond-laser assisted cataract surgery…
Read More
Just about two weeks after getting Food and Drug Administration (FDA) clearance for its corneal crosslinking platform, Avedro Chief Medical Officer Rajesh K. Raipal, MD,…
Read More
Robert Dempsey, Vice President and Business Unit Head of Ophthalmology, Shire. See below for the Video Timestamp: 00:30 – How do you build a brand…
Read More
Michael Onuscheck, global surgical franchise head for Alcon, a Novartis company, outlined the firm’s approach to innovation within the premium channel, which involves both internal…
Read More
Over the past year, Abbott Medical Optics (AMO) has established a leading share position in the US PC-IOL market, driven by the new low-add-power Tecnis…
Read More
Bausch + Lomb, a Valeant Pharmaceuticals company, remains the only firm with an FDA-approved accommodating IOL, the Crystalens AO. Andrew Chang, general manager and senior…
Read More
Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, shares how his company’s long history in ophthalmology helps it pave a path for…
Read More
Ophthalmology veteran Tom Frinzi joins OISTV to share his reasons for joining Abbott Medical Optics and what the company may be planning in coming years.…
Read More
The termination of the Pfizer-Allergan merger actually left some in ophthalmology feeling relief. We ask Bill Meury of Allergan how did Allergan employees feel about…
Read More
Ashley McEvoy, Company Chair of Vision Care and Diabetes at Johnson & Johnson, joins OISTV to discuss Johnson & Johnson’s commitment to eye health. Video…
Read More
Calvin Roberts, MD, CMO at Bausch & Lomb lends his physician’s perspective to how companies like Bausch & Lomb can serve eye care. Video Highlights…
Read More
SUBSCRIBE TO OIS NEWS
Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
We respect your privacy and promise to never send you spam.
![OIS-ANTERIOR-NEW-DATE-750x420[4300]](https://ois.net/wp-content/uploads/2020/03/OIS-ANTERIOR-NEW-DATE-750x4204300.jpg "OIS-ANTERIOR-NEW-DATE-750x420[4300]")